http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106117578-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8535a0af0a1a959054cc13bddcfd23d7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2389-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J5-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L89-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J5-18
filingDate 2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b535f315cedcd23d06401fa541e0bce7
publicationDate 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106117578-A
titleOfInvention A kind of preparation method of antibiotic-peptide modified-fibroin film material
abstract The invention discloses the preparation method of a kind of fibroin film material, it is desirable to provide a kind of preparation method being prepared novel antibiotic property fibroin film material by covalent modification.Including Na 2 CO 3 Solution nett silk protein raw materials remove impurity, lithium bromide water solution dissolving, dry, ethanol and the mixed liquid dipping of water, phosphate buffer immersion, EDCHCl/NHS solution soaking, phosphate buffer soaking flushing, dry step.The present invention, by the regulation concentration of fibroin, the concentration of antibacterial peptide solution and the condition of covalent modification, can reach effectively to control the purpose of material anti-microbial property.This membrane material had both had the 26S Proteasome Structure and Function of natural animal fibroin, has again antibacterial surface activity, and antibiotic property is lasting, gentle, will not produce drug resistance.Thus solve the antibacterial infection problems that natural animal fibroin material is likely to occur in clinical practice uses.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110038162-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110038162-A
priorityDate 2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID253143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447612385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID253143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422071869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18381240

Total number of triples: 37.